These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3696491)

  • 1. Ganglioside GM1 treatment prevents the effects of subacute exposure to toluene on N-[3H]propylnorapomorphine binding characteristics in rat striatal membranes.
    von Euler G; Fuxe K; Agnati LF; Hansson T; Gustafsson JA
    Neurosci Lett; 1987 Nov; 82(2):181-4. PubMed ID: 3696491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin modulates the binding characteristics of dopamine D2 receptors in rat striatal membranes also following treatment with toluene.
    von Euler G; Fuxe K; Benfenati F; Hansson T; Agnati LF; Gustafsson JA
    Acta Physiol Scand; 1989 Apr; 135(4):443-8. PubMed ID: 2525310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic treatment with morphine on the binding of 3H-N-n-propylnorapomorphine to striatal membranes of rats: influence of prolyl-leucyl-glycinamide.
    Das S; Bhargava HN
    Pharmacology; 1985; 31(5):241-7. PubMed ID: 2866551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subacute exposure to low concentrations of toluene affects dopamine-mediated locomotor activity in the rat.
    von Euler G; Ogren SO; Bondy SC; McKee M; Warner M; Gustafsson JA; Eneroth P; Fuxe K
    Toxicology; 1991 May; 67(3):333-49. PubMed ID: 1828635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
    Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
    Srivastava LK; Bajwa SB; Johnson RL; Mishra RK
    J Neurochem; 1988 Mar; 50(3):960-8. PubMed ID: 2892892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of toluene treatment in vivo and in vitro on the binding characteristics of [3H]neurotensin in rat striatal membranes.
    von Euler G; Fuxe K; Hansson T; Gustafsson JA
    Toxicology; 1988 Apr; 49(1):149-54. PubMed ID: 2836971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside GM1 counteracts the enhancing effects of subacute toluene exposure on apomorphine-induced locomotor activity.
    von Euler G; Ogren SO; Fuxe K; Gustafsson JA
    Toxicol Lett; 1992 Nov; 63(2):165-9. PubMed ID: 1455448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic dihydroergotoxine treatment affects the number of dopamine recognition sites in rat striatum.
    Battaini F; Govoni S; Rius RA; Spano PF; Trabucchi M
    Pharmacol Res Commun; 1984 Jun; 16(6):605-11. PubMed ID: 6463097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent effects of subchronic toluene exposure on spatial learning and memory, dopamine-mediated locomotor activity and dopamine D2 agonist binding in the rat.
    von Euler G; Ogren SO; Li XM; Fuxe K; Gustafsson JA
    Toxicology; 1993 Mar; 77(3):223-32. PubMed ID: 8096348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
    Hall MD; Jenner P; Kelly E; Marsden CD
    Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. l-Glutamate reduces the affinity of [3H]N-propylnorapomorphine binding sites in striatal membranes.
    Fuxe K; Celani MF; Martire M; Zini I; Zoli M; Agnati LF
    Eur J Pharmacol; 1984 Apr; 100(1):127-30. PubMed ID: 6144551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3H]N-n-propylnorapomorphine binding sites.
    Dubois A; Scatton B
    Neurosci Lett; 1985 Jun; 57(1):7-12. PubMed ID: 3162114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of GM1 ganglioside treatment on the recovery of dopaminergic nigro-striatal neurons after different types of lesion.
    Toffano G; Agnati LF; Fuxe K; Aldinio C; Consolazione A; Valenti G; Savoini G
    Acta Physiol Scand; 1984 Nov; 122(3):313-21. PubMed ID: 6151339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic dysfunction in neonatal hypothyroidism: differential effects of GM1 ganglioside.
    Vaccari A; Stefanini E; de Montis G; Rossetti ZL
    Neuropharmacology; 1990 Dec; 29(12):1161-9. PubMed ID: 2149873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo binding of N-n-propylnorapomorphine in the rat striatum: quantification after lesions produced by kainate, 6-hydroxydopamine and decortication.
    Van der Werf JF; Sebens JB; Korf J
    Eur J Pharmacol; 1984 Jul; 102(2):251-9. PubMed ID: 6434329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM1 ganglioside treatment promotes recovery of electrically-stimulated [3H]dopamine release in striatal slices from rats lesioned with kainic acid.
    Raiteri M; Bonanno G; Pende M; Versace P
    Neurosci Lett; 1992 Feb; 136(1):127-30. PubMed ID: 1321965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kainate lesion dissociates striatal dopamine receptor radioligand binding sites.
    Leff S; Adams L; Hyttel J; Creese I
    Eur J Pharmacol; 1981 Mar; 70(1):71-5. PubMed ID: 7215442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ganglioside GM1 prevents and reverses toluene-induced increases in membrane fluidity and calcium levels in rat brain synaptosomes.
    von Euler G; Fuxe K; Bondy SC
    Brain Res; 1990 Feb; 508(2):210-4. PubMed ID: 2306612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM1 monosialoganglioside inner ester induces early recovery of striatal dopamine uptake in rats with unilateral nigrostriatal lesion.
    Raiteri M; Versace P; Marchi M
    Eur J Pharmacol; 1985 Dec; 118(3):347-50. PubMed ID: 4085560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.